Patent · US Active

Fused ring heterocycle kinase modulators

US8242280B2 · kind B2 · utility

4Cited by
11References
20Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 10, 2008
Grant dateAug 14, 2012
Priority date
Expiry dateJun 5, 2031

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P37/08
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention provides fused ring heterocycles as kinase modulators, pharmaceutical compositions containing these modulators, and methods of using these modulators to treat diseases mediated by kinase activity.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.